Noveome Biotherapeutics, Inc.
Amendment
CIK: 0001478304·Biotechnology·DELAWARE·Filed: Aug 8, 2024
Total Offering
$51,270,077
Amount Sold
$36,184,531
Investors
66
First Sale
Aug 2, 2023
Offering Details
- Type
- Equity
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Gretchen Kraemer | Related Person |
| Robert Langer | Related Person |
| Ronald Poropatich | Related Person |
| Eric Keller | Related Person |
| Houman Hemmati | Related Person |
| Craig Nemiroff | Related Person |
| Michael Kaufman | Related Person |
| Patrick Welch | Related Person |
Company
SEC Filing
0001478304-24-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free